Neural Mechanisms of the Social Brain

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study uses structural MRI to locate stimulation sites and randomizes participants to different TMS target locations. A two to three day lead-in fNIRS session precedes the TMS procedures, followed by a dyadic neuroimaging session after stimulation. In separate sessions, tDCS will be applied with sites chosen from individual MRI scans, and all participants will complete a face-gaze fNIRS task to probe social processing. The goal is to identify neural hubs whose disruption modulates eye contact and live face gaze, informing future neuromodulation approaches in social neuroscience.

Why it matters

Who can join: the full rules

Inclusion Criteria:

-Self reported typically developed adults.

Exclusion Criteria:

-No prior history of seizure activity. Self reported absence of recreational drugs at time of study.

Where it's running

• Yale School of Medicine
  New Haven, Connecticut, United States Recruiting

Study contacts

• Principal investigator: Joy Hirsch, PhD — Yale University
• Study coordinator: Joy Hirsch, PhD
• Email: joy.hirsch@yale.edu
• Phone: 9174947768

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pet imaging of sigma1 receptors in healthy adults

  This study tests two sigma-1 radiotracers, to see how well they image the brain in healthy adults and how reliably the imaging measurements work.

  Recruiting Phase 1 Yale University · New Haven, Connecticut · NCT07915323

• Intradermal Flu Vaccine After All: Watching Immune Response in Skin and Blood

  This study tests whether giving the seasonal flu shot into the skin (instead of muscle) changes the immune response in healthy adults, cancer patients about to start immunotherapy, and people with post-acute infection syndromes.

  Recruiting Early Phase 1 Yale University · New Haven, Connecticut · NCT07908329

• CBD for Opioid Dependence and Pain on Buprenorphine

  This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.

  Recruiting Early Phase 1 Yale University · West Haven, Connecticut · NCT07886606

• CB1 Receptors in Opioid Use Disorder Measured with a PET Radioligand

  This study tests CB1 receptor availability in people with opioid use disorder starting opioid agonist therapy and compares them with healthy adults.

  Recruiting Phase 1 Yale University · New Haven, Connecticut · NCT07800520

• Greater Occipital Nerve Blockade for Veterans with Post-Traumatic Headache

  This study tests whether injecting tiny amounts of anesthesia into the greater occipital nerve can reduce headache days for veterans with chronic post-traumatic headaches.

  Recruiting Phase 2 Yale University · West Haven, Connecticut · NCT07796074

• Adaptive Decision Support for Addiction Treatment: Testing a Care Tool for ED Doctors to Help Buprenorphine Use

  We’re testing a refined decision-support tool in emergency departments to help doctors prescribe buprenorphine to adults with moderate to severe opioid use disorder.

  Recruiting at 3 sites Yale University · Guilford, Connecticut and 2 other locations · NCT07793383

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.